Skip header and navigation
  • All Records

328 records – page 1 of 33.

Document Type
Table
Review Code
EOC220304v002 RR Table
Question Submitted
March 29, 2022
Date Completed
June 7, 0222
Status
3. Completed
Research Team
EOC
Document Type
Table
Review Code
EOC220304v002 RR Table
Question Submitted
March 29, 2022
Date Completed
June 7, 0222
Status
3. Completed
Research Team
EOC
Category
Healthcare Services
Infection Prevention and Control
Subject
Clinical Presentation
Immunity
Infection Prevention and Control
Vaccines
Population
All
Clinical Setting
Community
Primary care
Public Health
Priority Level
Level 1 2-3 days
Cite As
Badea, A; Groot, G; Reeder, B; Dalidowicz, M; Howell-Spooner, B. What is the efficacy of a 4th booster dose for COVID-19? 2022 Jun 7. Document no.: EOC220304v002 RR Table. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2022. (CEST table).
Similar Reviews
INF031801v020 ESR
INF031801v019 RR
Related Documents
Documents

EOC220304v002 RR Table

Download File
Less detail
Document Type
Evidence Search Report
Review Code
EOC032401-01 ESR
Question Submitted
March 24, 2020
Date Completed
March 24, 2020
Status
5. Updated review
Research Team
EOC
Document Type
Evidence Search Report
Review Code
EOC032401-01 ESR
Question Submitted
March 24, 2020
Date Completed
March 24, 2020
Status
5. Updated review
Research Team
EOC
Category
Clinical Presentation
Subject
Immunity
Population
All
Priority Level
Level 2 completed within 8 hours
Cite As
Dalidowicz, M. What is the risk of reinfection from COVID-19? 2020 Mar 24; Document no.: EOC032401-01 ESR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 3 p. (CEST evidence search report)
Review History
EOC032401v2 RR: August 1, 2020
EOC032401 RR: May 14, 2020
Related Documents
Documents
Less detail
Document Type
Evidence Search Report
Review Code
EOC033001-01 ESR
Question Submitted
March 30, 2020
Date Completed
March 30, 2020
Status
3. Completed
Research Team
EOC
Document Type
Evidence Search Report
Review Code
EOC033001-01 ESR
Question Submitted
March 30, 2020
Date Completed
March 30, 2020
Status
3. Completed
Research Team
EOC
Category
Infection Prevention and Control
Subject
Intubation
Aerosols
Population
All
Clinical Setting
Ambulatory
Cardiac unit
Priority Level
Level 2 completed within 8 hours
Cite As
Dalidowicz, M. Where and how are they producing and using intubation hoods? 2020 Mar 30; Document no.: EOC033001-01 ESR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 6 p. (CEST evidence search report)
Related Documents
Documents
Less detail
Document Type
Evidence Search Report
Review Code
EOC033002-01 ESR
Question Submitted
March 30, 2020
Date Completed
March 30, 2020
Status
3. Completed
Research Team
EOC
Document Type
Evidence Search Report
Review Code
EOC033002-01 ESR
Question Submitted
March 30, 2020
Date Completed
March 30, 2020
Status
3. Completed
Research Team
EOC
Notes
This was never assigned to an RR
Category
Infection Prevention and Control
Healthcare Services
Subject
Facilities
Health Personnel
Population
All
Priority Level
Level 3 completed within 2-3 days
Cite As
Howell-Spooner, B. What approaches are effective to limit the spread of COVID-19 infection for healthcare workers in health facilities and how does it impact their mental health? 2020 Mar 30; Document no.: EOC033002-01 ESR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 20 p. (CEST evidence search report)
Related Documents
Documents
Less detail
Document Type
Evidence Search Report
Review Code
EOC033003-01 ESR
Question Submitted
March 30, 2020
Date Completed
March 30, 2020
Status
3. Completed
Research Team
EOC
Document Type
Evidence Search Report
Review Code
EOC033003-01 ESR
Question Submitted
March 30, 2020
Date Completed
March 30, 2020
Status
3. Completed
Research Team
EOC
Notes
This was never assigned to an RR
Category
Healthcare Services
Administration
Subject
Health Planning
Facilities
Acute Care
Modeling
Population
All
Priority Level
Level 2 completed within 8 hours
Cite As
Howell-Spooner, B. How do we decrease surge demand in acute care? 2020 Mar 30; Document no.: EOC033003-01 ESR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 10 p. (CEST evidence search report)
Related Documents
Documents
Less detail
Document Type
Evidence Search Report
Review Code
EOC033004-01 ESR
Question Submitted
March 30, 2020
Date Completed
March 30, 2020
Status
3. Completed
Research Team
EOC
Document Type
Evidence Search Report
Review Code
EOC033004-01 ESR
Question Submitted
March 30, 2020
Date Completed
March 30, 2020
Status
3. Completed
Research Team
EOC
Category
Infection Prevention and Control
Subject
Households
Transmission
Priority Level
Level 5 completed within 2 weeks
Cite As
Fox, L. What are effective methods to reduce disease transmission within households? 2020 Mar 30; Document no.: EOC033004-01 ESR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 7 p. (CEST evidence search report)
Related Documents
Documents
Less detail
Document Type
Rapid Review
Review Code
EOC033001 RR
Question Submitted
March 30, 2020
Date Completed
March 30, 2020
Status
3. Completed
Research Team
EOC
Document Type
Rapid Review
Review Code
EOC033001 RR
Question Submitted
March 30, 2020
Date Completed
March 30, 2020
Status
3. Completed
Research Team
EOC
Key Findings
· Some countries like Taiwan and Malaysia have created their own intubation hood design as others offered to produce or modify the original design to fit their country’s equipment. · Several countries have also created innovation in airway management such as 3D printed respirator valves for hospitals and 3D printed ventilators. · An Emergency physician in Northern Italy shared that due to influx of patients in the hospitals, “intubation and invasive mechanical ventilators in the ED are reserved for patients not responsive to NIV” although in principle can give a more favorable chance for patients if given before their condition deteriorates.
Category
Infection Prevention and Control
Subject
Intubation
Aerosols
Population
All
Clinical Setting
Ambulatory
Cardiac unit
Priority Level
Level 2 completed within 8 hours
Cite As
Badea, A; Groot, G; Dalidowicz, M. Where and how are they producing and using intubation hoods? 2020 Mar 30; Document no.: EOC033001 RR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 7 p. (CEST rapid review report)
Similar Reviews
EOC090202 RR
Related Documents
Documents
Less detail
Document Type
Evidence Search Report
Review Code
EOC033101-01 ESR
Question Submitted
March 31, 2020
Date Completed
March 31, 2020
Status
3. Completed
Research Team
EOC
Document Type
Evidence Search Report
Review Code
EOC033101-01 ESR
Question Submitted
March 31, 2020
Date Completed
March 31, 2020
Status
3. Completed
Research Team
EOC
Notes
No written rapid review
Category
Infection Prevention and Control
Subject
Aerosols
Surgical Procedures
Risk
Population
All
Clinical Setting
Medicine Unit
Priority Level
Level 2 completed within 8 hours
Cite As
Dalidowicz, M. What is the magnitude of risk of exposure to coronaviruses with intermediate and high risk upper GI endoscopy, ERCP and colonoscopy? 2020 Mar 31; Document no.: EOC033101-01 ESR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 9 p. (CEST evidence search report)
Related Documents
Documents
Less detail
Document Type
Evidence Search Report
Review Code
EOC033102-01 ESR
Question Submitted
March 31, 2020
Date Completed
March 31, 2020
Status
3. Completed
Research Team
EOC
Document Type
Evidence Search Report
Review Code
EOC033102-01 ESR
Question Submitted
March 31, 2020
Date Completed
March 31, 2020
Status
3. Completed
Research Team
EOC
Category
Clinical Presentation
Subject
Symptoms
Population
All
Priority Level
Level 2 completed within 8 hours
Cite As
Young, C. What percentage of COVID-19 patients have hyposmia or anosmia? 2020 Mar 31; Document no.: EOC033102-01 ESR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 7 p. (CEST evidence search report)
Related Documents
Documents
Less detail
Document Type
Evidence Search Report
Review Code
EOC040101-01 ESR
Question Submitted
April 1, 2020
Date Completed
April 1, 2020
Status
3. Completed
Research Team
EOC
Document Type
Evidence Search Report
Review Code
EOC040101-01 ESR
Question Submitted
April 1, 2020
Date Completed
April 1, 2020
Status
3. Completed
Research Team
EOC
Category
Epidemiology
Infection Prevention and Control
Subject
Aerosols
Risk
Transmission
Population
All
Clinical Setting
Ambulatory
Priority Level
Level 2 completed within 8 hours
Cite As
Dalidowicz, M; Young, C. What is the degree of COVID-19 transmission through the administration of nebulizer medication either in clinical practice or in animal experiments? 2020 Apr 1; Document no.: EOC040101-01 ESR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 12 p. (CEST evidence search report)
Related Documents
Documents
Less detail

328 records – page 1 of 33.